Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If more
information about the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03736473” into the
search box, and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D6070C00006” into the search box, and click “Find a Study”.
Full Study Title: A Phase I, Open-label Study to Assess the Safety, Tolerability,
Pharmacokinetics and Anti-tumour Activity of MEDI9447 (Oleclumab) in Japanese
Patients with Advanced Solid Malignancies
AstraZeneca Protocol Number: D6070C00006
AstraZeneca K.K. sponsored this study and has its headquarters at Grand Front Osaka
Tower B 3-1, Ofuka-cho, Kita-ku, Osaka 530-0011, Japan.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
Version 1.0_2020_12_03 8